Cellbxhealth (LON:CLBX) Posts Earnings Results

Cellbxhealth (LON:CLBX) released its quarterly earnings data on Wednesday. The company reported GBX (0.24) earnings per share for the quarter, Digital Look Earnings reports.

Cellbxhealth Price Performance

CLBX stock traded down GBX 0.07 during trading hours on Wednesday, reaching GBX 1.33. The stock had a trading volume of 900,639 shares, compared to its average volume of 4,237,635. Cellbxhealth has a fifty-two week low of GBX 0.85 and a fifty-two week high of GBX 2.70. The stock has a market cap of £15.13 million and a P/E ratio of -0.24.

About Cellbxhealth

CelLBxHealth plc is a precision CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology. Its patent-protected Parsortix® platform harvests CTCs from blood and can be integrated with existing laboratory instruments for comprehensive downstream analysis – including whole-cell imaging, proteomic profiling and full genomic workflows.
Commercial activities centre on (1) Product Sales: Accelerating Parsortix platform adoption and consumable sales through CROs and clinical lab partnerships.